Literature DB >> 19625964

Cognitive development following pediatric solid organ transplantation.

Estella M Alonso1, Lisa G Sorensen.   

Abstract

PURPOSE OF REVIEW: Cognitive development and school function are important psychosocial outcomes that should be monitored closely in children following transplantation. This review includes discussion of a small number of studies published within the past year and details future directions in this area of research. RECENT
FINDINGS: An analysis of school-aged kidney transplant recipients revealed normal intelligence, but suggested significant impairment in gross motor and fine motor skills. Another study of adults who received kidney transplantation as children revealed that these patients rated their quality of life relatively high despite ongoing medical problems, delayed educational goals and a higher rate of unemployment than the general population. Psychoeducational outcomes of 30 pediatric liver transplant recipients who had onset of chronic liver disease in early infancy revealed that 27% of the group had intelligence scores that were more than 2 standard deviations below test norms. Progress in studying these outcomes in heart and intestinal transplant recipients has been slow and there was no new report published in this time frame.
SUMMARY: There are considerable gaps in our knowledge of these types of outcomes, but current studies support neurocognitive delay as an important problem for children receiving organ transplantation.

Entities:  

Mesh:

Year:  2009        PMID: 19625964     DOI: 10.1097/MOT.0b013e3283307a62

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  9 in total

Review 1.  Primer on renal transplantation.

Authors:  Asha Moudgil
Journal:  Indian J Pediatr       Date:  2012-06-05       Impact factor: 1.967

Review 2.  Psychiatric issues in pediatric organ transplantation.

Authors:  Margaret L Stuber
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2010-04

3.  Pediatric Quality of Life Inventory (PedsQL) in Fragile X Syndrome.

Authors:  Sarah E Fitzpatrick; Lauren M Schmitt; Ryan Adams; Ernest V Pedapati; Logan K Wink; Rebecca C Shaffer; Jessica Sage; Jayne Dixon Weber; Kelli C Dominick; Craig A Erickson
Journal:  J Autism Dev Disord       Date:  2020-03

4.  Cognitive and adaptive functioning after liver transplantation for maple syrup urine disease: a case series.

Authors:  D A Shellmer; A DeVito Dabbs; M A Dew; R B Noll; H Feldman; K A Strauss; D H Morton; J Vockley; G V Mazariegos
Journal:  Pediatr Transplant       Date:  2010-10-08

Review 5.  The start of the transplant journey: referral for pediatric solid organ transplantation.

Authors:  Diana Shellmer; Cheryl Brosig; Jo Wray
Journal:  Pediatr Transplant       Date:  2014-01-20

6.  NUTORC-a transdisciplinary health services and outcomes research team in transplantation.

Authors:  Daniela P Ladner; Estella M Alonso; Zeeshan Butt; Juan Carlos Caicedo; David Cella; Amna Daud; John J Friedewald; Elisa J Gordon; Gordon B Hazen; Bing T Ho; Kathleen R Hoke; Jane L Holl; Michael G Ison; Raymond Kang; Sanjay Mehrotra; Luke B Preczewski; Olivia A Ross; Pamela H Sharaf; Anton I Skaro; Edward Wang; Michael S Wolf; Donna M Woods; Michael M Abecassis
Journal:  Transl Behav Med       Date:  2012-12       Impact factor: 3.046

Review 7.  Post-transplant adjustment--the later years.

Authors:  Emily M Fredericks; Nataliya Zelikovsky; Isabelle Aujoulat; Anna Hames; Jo Wray
Journal:  Pediatr Transplant       Date:  2014-09-13

8.  Adaptive functioning and its correlates after intestine and liver transplantation.

Authors:  Diana A Shellmer; Annette DeVito Dabbs; Mary Amanda Dew; Lauren Terhorst; Robert B Noll; Beverly Kosmach-Park; George Mazariegos
Journal:  Pediatr Transplant       Date:  2012-11-08

Review 9.  Executive Functioning in Pediatric Solid Organ Transplant Recipients: A Meta-analytic Review.

Authors:  Grace K Cushman; Mary Gray Stolz; Ronald L Blount; Bonney Reed
Journal:  Transplantation       Date:  2020-02       Impact factor: 5.385

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.